Beranda › Skleroderma › Illinois › Chicago
Uji klinis Skleroderma di Chicago, IL
10 studi untuk Skleroderma mencari peserta di lokasi sekitar Chicago (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Menerima pesertaFase 3
- Northwestern University, Chicago
- The University of Chicago Medical Center, Chicago
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Menerima pesertaFase 2
- University of Illinois Health Outpatient Care Center, Chicago
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Menerima pesertaFase 1
- The University of Chicago Medical Center, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Menerima pesertaFase 2/3
- GSK Investigational Site, Chicago
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Menerima pesertaFase 1
- Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Platform Clinical Study for Conquering Scleroderma
Menerima pesertaFase 2
- The University of Chicago Medical Center (UCMC), Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Menerima pesertaFase 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Menerima pesertaFase 1/2
- Nkarta Investigational Site, Chicago
A Study of AZD0120 in Autoimmune Diseases
Menerima pesertaFase 1
- Research Site, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Menerima pesertaFase 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Uji klinis Skleroderma di kota lain
- New York City, NY11 studi
- Ann Arbor, MI10 studi
- Houston, TX9 studi
- Boston, MA7 studi
- Durham, NC7 studi
- Los Angeles, CA7 studi
- New Orleans, LA6 studi
- Philadelphia, PA6 studi
- Baltimore, MD6 studi
- Dallas, TX5 studi
- Pittsburgh, PA5 studi
- Plantation, FL4 studi
Studi lain di Chicago
- Kanker Paru Non-Sel Kecil61 studi
- Kanker Payudara58 studi
- Kanker (semua jenis)51 studi
- Kanker Metastatik45 studi
- Kanker Prostat45 studi
- Obesitas41 studi
- Kanker Paru41 studi
- Kanker Ovarium36 studi
- Stroke34 studi
- Kanker Kolorektal33 studi
- Gagal Jantung31 studi
- Kelebihan Berat Badan28 studi
Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.